Cancer drugs and public preferences
Last year the UK government announced the establishment of a £600 million cancer drug fund, to be spent over 3 years. This represents a minuscule amount of money compared to the NHS’s annual budget,...
View ArticleRationing and deprivation in risk sharing schemes
Here in the UK, NICE sometimes advises against the provision of particular drugs, by the NHS, on the grounds that evidence does not indicate them to be cost-effective. In some cases it appears that...
View Article
More Pages to Explore .....